Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
- Response deadline
- Dec 3, 2027 Due in 457 days
- Date posted
- Dec 5, 2024
- Source
- Open notice
Description
The purpose of this notice of funding opportunity (NOFO) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of drug using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of drug abuse and HIV.
Classifications
- NAICS93.273
Documents (1)
- DownloadRFA-DA-26-056-Full-Announcement.htmltext/html429 B
Contacts
- grantsinfo@nih.gov301-402-2541
Similar contracts
- Predoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)Due Apr 8, 2029
- Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)Due Jan 7, 2027
- Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)Due Jan 7, 2028
- Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)Due Dec 3, 2027
- Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)Due Sep 7, 2026
- Alcohol Health Services Research (R01 Clinical Trial Optional)Due Sep 7, 2026